CA1215972A - Ergot alkaloids - Google Patents

Ergot alkaloids

Info

Publication number
CA1215972A
CA1215972A CA000434064A CA434064A CA1215972A CA 1215972 A CA1215972 A CA 1215972A CA 000434064 A CA000434064 A CA 000434064A CA 434064 A CA434064 A CA 434064A CA 1215972 A CA1215972 A CA 1215972A
Authority
CA
Canada
Prior art keywords
compound
alkyl
formula
pyridyl
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000434064A
Other languages
English (en)
French (fr)
Inventor
Peter Gull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1215972A publication Critical patent/CA1215972A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CA000434064A 1982-08-09 1983-08-08 Ergot alkaloids Expired CA1215972A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (de) 1982-08-09 1982-08-09 Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
CH4772/82 1982-08-09

Publications (1)

Publication Number Publication Date
CA1215972A true CA1215972A (en) 1986-12-30

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000434064A Expired CA1215972A (en) 1982-08-09 1983-08-08 Ergot alkaloids

Country Status (23)

Country Link
JP (1) JPS5948480A (da)
AT (1) AT383125B (da)
AU (1) AU563736B2 (da)
BE (1) BE897473A (da)
CA (1) CA1215972A (da)
CH (1) CH649998A5 (da)
DE (1) DE3327705A1 (da)
DK (1) DK361983A (da)
ES (1) ES8502992A1 (da)
FI (1) FI73679C (da)
FR (1) FR2531433B1 (da)
GB (1) GB2125041B (da)
GR (1) GR78923B (da)
HU (1) HU187600B (da)
IL (1) IL69450A (da)
IT (1) IT1168961B (da)
MY (1) MY8700166A (da)
NL (1) NL8302776A (da)
NZ (1) NZ205181A (da)
PH (1) PH20385A (da)
PT (1) PT77168B (da)
SE (1) SE8304315L (da)
ZA (1) ZA835850B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
FR2531433A1 (fr) 1984-02-10
FI73679B (fi) 1987-07-31
FR2531433B1 (fr) 1985-10-18
NZ205181A (en) 1986-07-11
FI73679C (fi) 1987-11-09
GR78923B (da) 1984-10-02
DK361983D0 (da) 1983-08-08
HU187600B (en) 1986-01-28
FI832789A0 (fi) 1983-08-02
GB2125041B (en) 1986-04-23
JPS5948480A (ja) 1984-03-19
CH649998A5 (de) 1985-06-28
IT8322490A0 (it) 1983-08-09
GB8321222D0 (en) 1983-09-07
PT77168B (en) 1986-03-27
DK361983A (da) 1984-02-10
IT1168961B (it) 1987-05-20
GB2125041A (en) 1984-02-29
PT77168A (en) 1983-09-01
AU1767283A (en) 1984-02-16
ZA835850B (en) 1985-03-27
SE8304315L (sv) 1984-02-10
FI832789L (fi) 1984-02-10
IL69450A (en) 1986-10-31
SE8304315D0 (sv) 1983-08-08
NL8302776A (nl) 1984-03-01
DE3327705A1 (de) 1984-02-09
ATA286383A (de) 1986-10-15
IL69450A0 (en) 1983-11-30
AT383125B (de) 1987-05-25
PH20385A (en) 1986-12-08
ES524815A0 (es) 1985-02-01
AU563736B2 (en) 1987-07-23
MY8700166A (en) 1987-12-31
ES8502992A1 (es) 1985-02-01
BE897473A (fr) 1984-02-06

Similar Documents

Publication Publication Date Title
RU2124002C1 (ru) Производные амидина, смесь их изомеров или отдельные изомеры и их соли, фармацевтическая композиция, обладающая антагонистическим действием в отношении лейкотриена b4
EP0082808B1 (en) Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents
EP0092391A2 (en) Novel piperidine derivatives and pharmaceutical compositions containing same
EP1975168A1 (en) Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation
TW202328115A (zh) Glp-1受體激動劑的結晶形式及其製備方法
CA1056836A (en) 2,6-disubstituted 2-phenylimino-imidazolidines their acid addition salts, pharmaceuticals containing same and processes for their production
DE69411143T2 (de) Tryptamin analoge mit 5-ht1d selektivität
EP1400510B1 (en) Cyclic diamine compounds having fused-ring groups
US4634708A (en) Indolophenanthridines useful as dopaminergic and analgesic agents
GB2125041A (en) Ergot alkaloids
HUT74726A (en) Quinuclidine and azabicyclo[2,2,1]-heptane-pyrazinyl-ethers as muscarinic agonists
EP1282617B1 (en) Hydantoin derivatives with affinity for somatostatin receptors
AU650569B2 (en) Imidazol-1-yl methyl pyridine derivatives, processes for their production and their use as pharmaceuticals
CA1252086A (en) Pyrazole derivatives with an ergoline skeleton, their acid addition salts, and a process for the preparation thereof
US4588725A (en) 2-piperazinyl-quinazoline derivatives and pharmaceutical compositions containing them
IE883136L (en) Ó(2)-adreno receptor antagonists
US5418235A (en) Aminoalkyl-substituted 5-mercaptothiazoles, the preparation and use thereof
HK56697A (en) Substituted piperazines, their process of preparation and the pharmaceutical compositions containing them
Saccomanni et al. Synthesis and β-blocking activity of (R, S)-(E)-oximeethers of 2, 3-dihydro-1, 8-naphthyridine and 2, 3-dihydrothiopyrano [2, 3-b] pyridine: identification of β3-antagonists
Mantegani et al. Synthesis and antihypertensive activity of 2, 4-dioxoimidazolidin-1-yl and perhydro-2, 4-dioxopyrimidin-1-yl ergoline derivatives
US5026701A (en) Morpholine compounds, compositions and use
US4931449A (en) 2-((4-piperidyl)methyl)benzofuro(2,3-C)pyridine derivatives, and their application in therapy
US7521472B2 (en) Crystal of two-ring heterocyclic sulfonamide compound
US5422353A (en) Tetrahydropyridine derivatives
PT99280B (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas

Legal Events

Date Code Title Description
MKEX Expiry